Actos Linked to Bladder Cancer
Posted on behalf of Edwards Law Firm on Oct 21, 2011 in Consumer Alerts
Recent research conducted by the U.S. Food and Drug Administration shows that there is a strong link between prolonged Actos-use and bladder cancer.
Pioglitazone, the active ingredient in Actos, is an oral medication prescribed to patients with Type 2 diabetes. The FDA is currently conducting a ten-year-long study exploring the link between Actos and bladder cancer.
At the 5-year mark of the study, the FDA has released information to the public that patients who have used Actos for over a year are 40% more likely to develop bladder cancer.
Side effects associated with the use of Actos include:
- Blood in urine
- Back or lower abdominal pain
- Urgent need to urinate
- Pain during urination
If you or a loved one has experienced any of these symptoms, stop taking Actos immediately and consult with a pharmaceutical injury attorney at the Edwards Law Firm to see if you have cause for an Actos lawsuit.
The Takeda Pharmaceutical Company, manufacturers of Actos, failed to warn consumers of the possible risk. The FDA has enforced the addition of a Black Box warning label in light of their findings.
For more information on Actos, or to schedule a free, no-obligation consultation with an Actos lawyer, contact a trusted Tulsa personal injury lawyer at the Edwards Law Firm today at 1-1-800-304-9246.